Mohs micrographic surgery for Basal cell carcinoma of the face

Affiliations

¹ Department of Dermatologic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, ECC-2, Boston, MA 02215, USA. ddo@bidmc.harvard.edu

Comment

Daihung Do. Arch Dermatol. 2009 Dec.

. 2009 Dec;145(12):1428-30.

doi: 10.1001/archdermatol.2009.315.

¹ Department of Dermatologic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, ECC-2, Boston, MA 02215, USA. ddo@bidmc.harvard.edu

No abstract available

Comment on

Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.
Mosterd K, Krekels GA, Nieman FH, Ostertag JU, Essers BA, Dirksen CD, Steijlen PM, Vermeulen A, Neumann H, Kelleners-Smeets NW. Mosterd K, et al. Lancet Oncol. 2008 Dec;9(12):1149-56. doi: 10.1016/S1470-2045(08)70260-2. Epub 2008 Nov 17. Lancet Oncol. 2008. PMID: 19010733 Clinical Trial.